In 85 patients with early undifferentiated arthritis given a glucocorticoid injection, 3 months of baricitinib improved DAS more than NSAIDs (adjusted difference −0.52; p=0.01); methotrexate's gain was non-significant (−0.39; p=0.09). No significant difference at 12 months.
RCTn = 85
Nevins et al. Induction of Cure in Early Arthritis (I CEA): results of a randomised clinical trial to compare three treatment strategies in recent onset undifferentiated arthritis